EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Limited Efficacy of 3 mA Intensified tDCS of the Right Inferior Frontal Cortex for OCD Treatment: A Randomized, Double‐Blind, Sham‐Controlled Study

Atefeh Fatehi-Chenar, Mohsen Dadashi iD, Alireza Moradi, Soroush Lohrasbi, Abolfazl Ghoreishi, Arash Fazeli, Ricardo Salvador iD, Michael A Nitsche iD, Zahra Vaziri iD, Mohammad Ali Salehinejad iD

CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)

DOI: 10.1002/cns.70927 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 24.05.2026. Verfasst von Atefeh Fatehi-Chenar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Psychology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, Transcranial Direct Current Stimulation, Frontal Lobe, Prefrontal Cortex. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Transcranial direct current stimulation (tDCS) has been proposed for treating obsessive‐compulsive disorder (OCD) with advantages such as affordability and home‐use application. Despite a moderate therapeutic effect, previous findings have been mixed. This registered, randomized, double‐blind, sham‐controlled trial investigated the efficacy of an intensified tDCS protocol targeting the inferior frontal cortex (IFC), a relevant brain region for inhibitory control for OCD treatment.

Methods

Forty patients with OCD received 20 sessions of 3 mA intensified tDCS or sham tDCS in parallel groups. The active treatment included 20 sessions of 20‐min 3 mA stimulation delivered twice per day (in 2 weeks) with 20‐min between‐session intervals. Intervention efficacy, treatment response, and cognitive functions (response inhibition, cognitive flexibility, and sustained attention) were evaluated before and after the intervention and at 2‐week, 1‐month, and 3‐month follow‐ups.

Results

Blinding of patients was successful. Both groups experienced decreased OCD symptoms, anxiety, and depression. While the active tDCS group showed a significant reduction in all clinical measures from pre‐ to post‐intervention, no statistically significant between‐group differences were found. The active tDCS group showed a mean reduction of 22.38% in OCD symptoms from baseline to endpoint, with 20% (4/20) responding with ≥ 50% symptom reduction, compared to 15.25% and 0% (0/20) in the sham group. Cognitive assessments similarly revealed within‐group improvements over time, but no differences between groups.

Conclusions

3 mA tDCS over the right IFC showed limited efficacy for OCD treatment, likely confounded by placebo effects, suggesting that other targeted regions may be more promising for tDCS intervention. Trial Registration IRCT20230216057437N1

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obsessive-Compulsive DisorderTranscranial Direct Current StimulationFrontal LobePrefrontal CortexHumansDouble-Blind MethodFemaleMaleAdultTreatment OutcomeYoung AdultMiddle AgedPsychiatric Status Rating Scales

Stichwörter der Autor:innen

inferior frontal cortexobsessive‐compulsive disordertDCStranscranial direct current stimulation

Autor:innen und Institutionen

  • Department of Clinical Psychology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Department of Clinical Psychology, Kharazmi University, Tehran, Iran.
  • VESAL Rehabilitation Center, Kharazmi University, Karaj, Iran.
  • Department of Psychiatry, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Brain Modeling Department, Neuroelectrics Barcelona, Barcelona, Spain.
  • Department of Psychology and Neurosciences, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany.

ORCID-Profile: Mohsen Dadashi, Ricardo Salvador, Michael A Nitsche, Zahra Vaziri, Mohammad Ali Salehinejad

Zitieren

APA

Fatehi-Chenar, A., Dadashi, M., Moradi, A., Lohrasbi, S., Ghoreishi, A., Fazeli, A., Salvador, R., Nitsche, M. A., Vaziri, Z., & Salehinejad, M. A. (2026). Limited Efficacy of 3 mA Intensified tDCS of the Right Inferior Frontal Cortex for OCD Treatment: A Randomized, Double‐Blind, Sham‐Controlled Study. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70927

Vancouver

Fatehi-Chenar A, Dadashi M, Moradi A, Lohrasbi S, Ghoreishi A, Fazeli A, et al. Limited Efficacy of 3 mA Intensified tDCS of the Right Inferior Frontal Cortex for OCD Treatment: A Randomized, Double‐Blind, Sham‐Controlled Study. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70927

BibTeX
@article{FatehiChenar2026,
  author = {Fatehi-Chenar, Atefeh and Dadashi, Mohsen and Moradi, Alireza and Lohrasbi, Soroush and Ghoreishi, Abolfazl and Fazeli, Arash and Salvador, Ricardo and Nitsche, Michael A and Vaziri, Zahra and Salehinejad, Mohammad Ali},
  title = {Limited Efficacy of 3 mA Intensified tDCS of the Right Inferior Frontal Cortex for OCD Treatment: A Randomized, Double‐Blind, Sham‐Controlled Study},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {5},
  doi = {10.1002/cns.70927}
}
Kostenlos starten →